Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers
出版年份 2021 全文链接
标题
Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers
作者
关键词
-
出版物
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-18
DOI
10.1038/s41418-021-00869-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
- (2020) Andriy Marusyk et al. CANCER CELL
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- Cell Death in the Origin and Treatment of Cancer
- (2020) Andreas Strasser et al. MOLECULAR CELL
- The National Lung Matrix Trial of personalized therapy in lung cancer
- (2020) Gary Middleton et al. NATURE
- Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology
- (2019) Amit J. Sabnis et al. TRENDS IN MOLECULAR MEDICINE
- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
- (2019) O Hamid et al. ANNALS OF ONCOLOGY
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Apoptosis and Clearance of Apoptotic Cells
- (2018) Shigekazu Nagata Annual Review of Immunology
- CDK9 inhibitors in acute myeloid leukemia
- (2018) Silvia Boffo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- BCL-2 inhibition in AML: an unexpected bonus?
- (2018) Marina Konopleva et al. BLOOD
- BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
- (2018) Delphine Merino et al. CANCER CELL
- Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
- (2018) Sunilkumar Kakadia et al. OncoTargets and Therapy
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
- (2017) Anna-Laura Kretz et al. TUMOR BIOLOGY
- Targeting cell death signalling in cancer: minimising ‘Collateral damage’
- (2016) Joanna L Fox et al. BRITISH JOURNAL OF CANCER
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment
- (2016) Yinshi Huang et al. CLINICAL CANCER RESEARCH
- Targeting CDK9: a promising therapeutic opportunity in prostate cancer
- (2016) Muhammed H Rahaman et al. ENDOCRINE-RELATED CANCER
- Genetics and biology of pancreatic ductal adenocarcinoma
- (2016) Haoqiang Ying et al. GENES & DEVELOPMENT
- Combine and conquer: challenges for targeted therapy combinations in early phase trials
- (2016) Juanita S. Lopez et al. Nature Reviews Clinical Oncology
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Targeting TRAIL in the treatment of cancer: new developments
- (2015) Bora Lim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers
- (2015) Giorgio G. Galli et al. MOLECULAR CELL
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
- (2014) M H Tuthill et al. ONCOGENE
- Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
- (2013) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis
- (2013) Meritxell Huch et al. EMBO JOURNAL
- Isolation, culture and genetic manipulation of mouse pancreatic ductal cells
- (2013) Maximilian Reichert et al. Nature Protocols
- Cyclin-dependent kinase inhibitors move into Phase III
- (2012) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
- (2010) D Lecis et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More